Morgan Stanley’s Actinium Pharmaceuticals ATNM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.6K Sell
44,700
-21,058
-32% -$29.5K ﹤0.01% 6281
2025
Q1
$106K Sell
65,758
-150,376
-70% -$242K ﹤0.01% 5985
2024
Q4
$272K Buy
216,134
+102,443
+90% +$129K ﹤0.01% 5672
2024
Q3
$214K Buy
113,691
+19,738
+21% +$37.1K ﹤0.01% 5733
2024
Q2
$695K Buy
93,953
+23,297
+33% +$172K ﹤0.01% 5148
2024
Q1
$553K Sell
70,656
-128,438
-65% -$1.01M ﹤0.01% 5270
2023
Q4
$1.01M Buy
199,094
+150,808
+312% +$766K ﹤0.01% 5286
2023
Q3
$286K Sell
48,286
-11,580
-19% -$68.6K ﹤0.01% 5425
2023
Q2
$444K Sell
59,866
-40,019
-40% -$297K ﹤0.01% 5278
2023
Q1
$944K Buy
99,885
+59,412
+147% +$561K ﹤0.01% 4897
2022
Q4
$431K Sell
40,473
-9,699
-19% -$103K ﹤0.01% 5318
2022
Q3
$370K Buy
50,172
+1,517
+3% +$11.2K ﹤0.01% 5424
2022
Q2
$234K Buy
48,655
+28,247
+138% +$136K ﹤0.01% 5814
2022
Q1
$104K Sell
20,408
-10,161
-33% -$51.8K ﹤0.01% 6277
2021
Q4
$184K Sell
30,569
-13,403
-30% -$80.7K ﹤0.01% 6117
2021
Q3
$390K Buy
43,972
+22,483
+105% +$199K ﹤0.01% 5643
2021
Q2
$170K Buy
21,489
+16,900
+368% +$134K ﹤0.01% 6089
2021
Q1
$35K Buy
4,589
+1,300
+40% +$9.92K ﹤0.01% 6512
2020
Q4
$26K Sell
3,289
-30,458
-90% -$241K ﹤0.01% 6360
2020
Q3
$327K Buy
33,747
+32,658
+2,999% +$316K ﹤0.01% 4860
2020
Q2
$11K Buy
1,089
+568
+109% +$5.74K ﹤0.01% 6132
2020
Q1
$3K Buy
521
+104
+25% +$599 ﹤0.01% 6309
2019
Q4
$3K Sell
417
-43
-9% -$309 ﹤0.01% 6449
2019
Q3
$3K Hold
460
﹤0.01% 6425
2019
Q2
$3K Sell
460
-34
-7% -$222 ﹤0.01% 6391
2019
Q1
$7K Sell
494
-4
-0.8% -$57 ﹤0.01% 6259
2018
Q4
$6K Sell
498
-84
-14% -$1.01K ﹤0.01% 6260
2018
Q3
$12K Buy
582
+37
+7% +$763 ﹤0.01% 6263
2018
Q2
$10K Sell
545
-10
-2% -$183 ﹤0.01% 6300
2018
Q1
$6K Sell
555
-283
-34% -$3.06K ﹤0.01% 6358
2017
Q4
$16K Sell
838
-34
-4% -$649 ﹤0.01% 6129
2017
Q3
$15K Buy
872
+1
+0.1% +$17 ﹤0.01% 6092
2017
Q2
$32K Sell
871
-3
-0.3% -$110 ﹤0.01% 5968
2017
Q1
$40K Sell
874
-656
-43% -$30K ﹤0.01% 5895
2016
Q4
$40K Sell
1,530
-1,394
-48% -$36.4K ﹤0.01% 5809
2016
Q3
$118K Buy
2,924
+361
+14% +$14.6K ﹤0.01% 5240
2016
Q2
$136K Buy
2,563
+611
+31% +$32.4K ﹤0.01% 5104
2016
Q1
$117K Sell
1,952
-25
-1% -$1.5K ﹤0.01% 5240
2015
Q4
$191K Buy
1,977
+544
+38% +$52.6K ﹤0.01% 5108
2015
Q3
$76K Sell
1,433
-1,066
-43% -$56.5K ﹤0.01% 5550
2015
Q2
$199K Buy
2,499
+798
+47% +$63.5K ﹤0.01% 5233
2015
Q1
$126K Buy
1,701
+290
+21% +$21.5K ﹤0.01% 5430
2014
Q4
$249K Buy
1,411
+1,201
+572% +$212K ﹤0.01% 5111
2014
Q3
$42K Buy
210
+126
+150% +$25.2K ﹤0.01% 5786
2014
Q2
$18K Buy
+84
New +$18K ﹤0.01% 6050